Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Briley

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brainC Moret, M Briley
European Journal of Pharmacology|January 11, 1996
Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brainC Moret, M Briley
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitorP Boyer, M Briley
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: pharmacogenomics of psychiatric disorders--separating the dreams from the realitiesM Briley, C Moret
Psychopharmacology|January 1, 1993
The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-mazeP Chopin, M Briley
Clinical Neuropharmacology|October 1, 1993
Neurobiological mechanisms involved in antidepressant therapiesM Briley, C Moret
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesisC Moret, M Briley
Expert Opinion on Investigational Drugs|July 5, 2005
Pasteur Euroconference on future therapies for an anxious worldM Briley, G Fillion
Psychiatry Research|August 1, 1991
Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the ratC Moret, M Briley
Trends in Pharmacological Sciences|August 1, 1988
The "forgotten" amino acid pyroglutamateC Moret, M Briley
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brainC Moret, M Briley
European Journal of Pharmacology|January 11, 1996
Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brainC Moret, M Briley
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitorP Boyer, M Briley
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Overview: pharmacogenomics of psychiatric disorders--separating the dreams from the realitiesM Briley, C Moret
Psychopharmacology|January 1, 1993
The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-mazeP Chopin, M Briley
Clinical Neuropharmacology|October 1, 1993
Neurobiological mechanisms involved in antidepressant therapiesM Briley, C Moret
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesisC Moret, M Briley
Expert Opinion on Investigational Drugs|July 5, 2005
Pasteur Euroconference on future therapies for an anxious worldM Briley, G Fillion
Psychiatry Research|August 1, 1991
Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the ratC Moret, M Briley
Trends in Pharmacological Sciences|August 1, 1988
The "forgotten" amino acid pyroglutamateC Moret, M Briley
Pageof 17